---
title: "Zhengchuan Pharmapack: In 2024, the net profit is expected to be 53.2488 million yuan, a year-on-year increase of 32.24%, and it plans to distribute 2.46 yuan per 10 shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235196496.md"
description: "Zhengchuan Pharmapack announced that in the 2024 annual report, the net profit attributable to shareholders of the listed company was 53.2488 million yuan, an increase of 32.24% year-on-year. The company plans to distribute a cash dividend of 2.46 yuan for every 10 shares based on the total share capital on the equity distribution record date to all shareholders. The total cash dividend for the year is 52.3159 million yuan, accounting for 98.25% of the net profit attributable to shareholders of the listed company in the 2024 consolidated financial statements"
datetime: "2025-04-09T10:12:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235196496.md)
  - [en](https://longbridge.com/en/news/235196496.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235196496.md)
generator: "portal-rs"
---

# Zhengchuan Pharmapack: In 2024, the net profit is expected to be 53.2488 million yuan, a year-on-year increase of 32.24%, and it plans to distribute 2.46 yuan per 10 shares

Zhengchuan Pharmapack announced that in the 2024 annual report, the net profit attributable to shareholders of the listed company was 53.2488 million yuan, an increase of 32.24% year-on-year. The company plans to distribute a cash dividend of 2.46 yuan for every 10 shares based on the total share capital on the equity distribution registration date to all shareholders. The total cash dividend for this year is 52.3159 million yuan, accounting for 98.25% of the net profit attributable to shareholders of the listed company in the 2024 consolidated financial statements

### Related Stocks

- [603976.CN](https://longbridge.com/en/quote/603976.CN.md)

## Related News & Research

- [Fosun turns page after property writedowns, shifts focus back to growth](https://longbridge.com/en/news/297240299.md)
- [RCS - ZAGENO - ZAGENO and ORO Labs Partnership](https://longbridge.com/en/news/297046609.md)
- [Eden Research Reports Revenue Of £4.90 Million For 15 Months Ended 31 March 2026](https://longbridge.com/en/news/296994948.md)
- [Tesi says 37% of portfolio companies have environmental policy, 46% track emissions in 2025 survey](https://longbridge.com/en/news/296871592.md)
- [Exmar lines up five-year USD senior unsecured bond sale after investor meetings kick off](https://longbridge.com/en/news/297269650.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**